The following people constitute the Editorial Board of Academic Editors for PeerJ. These active academics are the Editors who seek peer reviewers, evaluate their responses, and make editorial decisions on each submission to the journal. We will continue to add to the board of Academic Editors and are seeking qualified and diverse academics who share our vision.
Elizabeth (Liz) Wager is a freelance consultant and trainer with a background in publishing and medical writing who has worked on 6 continents. She chaired the Committee on Publication Ethics (2009-2012) and is a member of the Ethics Committees of the BMJ and the World Association of Medical Editors. She is a co-author of various COPE guidelines, Good Publication Practice for Pharmaceutical Companies, and wrote ‘Getting Research Published: An A to Z of Publication Strategy’ (2nd edition 2010).
Jennifer K. Wagner earned her JD from the University of North Carolina and her PhD in Anthropology from Penn State University. She completed post-doctoral research appointments at Duke University's Institute for Genome Sciences & Policy and the University of Pennsylvania's Center for the Integration of Genetic Healthcare Technologies. She is also a licensed attorney in PA. Jennifer is the 2014-2015 AAAS Science & Engineering Congressional Fellow.
Director of the McGill AIDS Centre and Professor of Medicine and of Microbiology at McGill University. Past President of the International AIDS Society and of the Canadian Association for HIV Research. Editor-in Chief of the Journal of the International AIDS Society and Editor of Retrovirology. Named a Chevalier de Légion d'honneur, 2008.
Recipient of the Wellcome Trust Senior Investigator Award (2011) and an ERC Advanced Grant (2011). Director of the European Workshop on Cell Death (EWCD) Charity.
Programme Leader at the Medical Research Council Protein Phosphorylation and Ubiquitylation Unit at the University of Dundee.
I am a statistician who works with biological and genomic datasets to understand the mechanisms underlying human disease and identify possible treatments. My main focus is on autoimmune diseases.
My background in is maths, and I gained my PhD in statistical genetics at the London School of Hygiene and Tropical Medicine in 2003. I now work at the Cambridge Institute for Medical Research (CIMR), where I am head of statistics in the Diabetes and Inflammation Laboratory.
Henry E. Wang, MD, MS, is Associate Professor and Vice Chair for Research, Department of Emergency Medicine, University of Alabama School of Medicine (Birmingham, Alabama, United States). Dr. Wang previously served as Emergency Medicine faculty at the University of Pittsburgh (Pittsburgh, Pennsylvania). Dr. Wang’s areas of scientific expertise include prehospital emergency care, paramedic airway management, therapeutic hypothermia, sepsis epidemiology and acute kidney injury.
Research Interests: To develop novel computational methods to analyze the fast increasing genomics, transcriptomics, proteomics and other large-scale biological data, to identify new non-coding regulatory RNA genes in eucaryotic genomes, to decipher their transcription regulatory mechanisms and to construct non-coding RNA involved gene regulatory networks.
Yong Wang is Research Associate Professor at the Academy of Mathematics and Systems Science (AMSS), Chinese Academy of Sciences (CAS). He is also a joint faculty member in the National Center for Mathematics and Interdisciplinary Sciences (NCMIS), Chinese Academy of Sciences. His current interest is in Optimization models and algorithms, Bioinformatics and Systems Biology.
I am an entomologist whose research interests are focused on the threats of invasive insects, the diversity of parasitoid communities, and the utilisation of data from natural history collections in ecological research.
Professor of Vascular Inflammation and Director of Graduate Studies at the William Harvey Research Institute, Barts and the London School of Medicine & Dentistry. Fellow of the American Heart Association. Fellow of the British Pharmacological Society. Fellow of the Society of Biology.
Head of the Mammalian Oocyte Meiosis (MOM) research group, at the Institut de Biologie Paris Seine (IBPS), Paris, France. She is currently a Research Director with the CNRS.
After her PhD in G. Ammerer's lab in Vienna on signal transduction in budding yeast, and a Postdoc in R. Benezra's lab (MSKCC, New York, USA) where she worked on mitotic checkpoint control in human cells, she decided to continue on cell cycle and spindle checkpoint control in oocyte meiosis.